Jupiter Diagnostics Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Employees
-
8
- Latest Deal Type
-
Liquidation
- Latest Deal Amount
-
$1.7M
Jupiter Diagnostics General Information
Description
Developer of nano crystal labelled technology designed to deliver high-quality affordable blood testing anywhere for medical diagnostics. The company's services include full scope of blood testing nearer to clinicians and patients and intuitive process that makes collecting blood tests easy, enabling healthcare practitioners to obtain accurate blood tests and thus make faster decisions.
Contact Information
Website
www.jupiterdiagnostics.comCorporate Office
- London BioSciences Innovation Centre
- 2 Royal College Street
- London NW1 0NH
- England, United Kingdom
Corporate Office
- London BioSciences Innovation Centre
- 2 Royal College Street
- London NW1 0NH
- England, United Kingdom
Jupiter Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Bankruptcy: Liquidation | 14-Mar-2019 | $1.7M | Completed | Bankruptcy: Liquidation | ||
| 2. Angel (individual) | 01-Apr-2018 | Completed | Startup | |||
| 1. Seed Round | 05-Apr-2017 | $1.96M | $1.96M | Completed | Startup |
Jupiter Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 6,676,535 | $0.013980 | $0.06 | $0.06 | 1x | $0.06 | 6.45% | |
| Ordinary | 222,642 | $0.013980 | $0.06 | $0.06 | 1x | $0.06 | 0.22% |
Jupiter Diagnostics Patents
Jupiter Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2751564-B1 | Methods of triggering activation of encapsulated signal-generating substances | Active | 30-Aug-2011 | ||
| EP-2751564-A1 | Methods of triggering activation of encapsulated signal-generating substances and apparatus utilising activated signal-generating substances | Active | 30-Aug-2011 | ||
| ES-2629929-T3 | Procedures to trigger the activation of encapsulated signal generating substances | Active | 30-Aug-2011 | G01N33/586 |
Jupiter Diagnostics Signals
Jupiter Diagnostics FAQs
-
When was Jupiter Diagnostics founded?
Jupiter Diagnostics was founded in 2015.
-
Where is Jupiter Diagnostics headquartered?
Jupiter Diagnostics is headquartered in London, United Kingdom.
-
What is the size of Jupiter Diagnostics?
Jupiter Diagnostics has 8 total employees.
-
What industry is Jupiter Diagnostics in?
Jupiter Diagnostics’s primary industry is Laboratory Services (Healthcare).
-
Is Jupiter Diagnostics a private or public company?
Jupiter Diagnostics is a Private company.
-
What is Jupiter Diagnostics’s current revenue?
The current revenue for Jupiter Diagnostics is .
-
How much funding has Jupiter Diagnostics raised over time?
Jupiter Diagnostics has raised $2.48M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process